// App-Quantinova.ai

: FREQUENCY OF HYDROXYCHLOROQUINE RETINOPATHY IN THE HOPKINS LUPUS COHORT

Researchers

Presenter

  • Michelle A Petri

Principal Investigators

  • Marwa Elkhalifa

  • LI Jessica

Medical Centers

  • The Johns Hopkins University, Baltimore, United States of America

  • Alexandria University, Internal Medicine, Alexandria, Egypt

Locations

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

Disease

  • Diabetic retinopathy

  • Lupus

Biomarkers

  • ETS transcription factor ERG

  • Interleukin 1 alpha

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • NIH and Pfizer

Result

  • N/A